Application and Benefits of Self-Activated Phthalocyanine in Dentistry: An Integrative Review
Article Sidebar
Main Article Content
Abstract
The objective of this study was to conduct an integrative literature review regarding the properties of Phthalocyanines and the benefits of their application in dentistry. A bibliographic search was conducted using the MEDLINE/PubMed database for the period from 2020 to 2022. The search terms used were "phthalocyanine" AND "dentistry." A total of 8 articles were included in the review. In vitro and in vivo studies demonstrated the self-activated phthalocyanine with potential antibacterial, antifungal, antibiofilm, antiviral effects, non-cytotoxic characteristics, and positive effects in complementary therapy for periodontal disease and tissue repair. Phthalocyanine exhibits excellent antimicrobial properties against bacteria, fungi, and viruses, along with low cytotoxicity, showing promising results in wound healing processes. It can be considered a suitable chemical agent for post-operative control.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
• The author (s) warrant that the contribution is original and unpublished and that it is not in the process of being evaluated in other journal (s);
• The journal is not responsible for the opinions, ideas and concepts issued in the texts, as they are the sole responsibility of the author (s);
• Publishers have the right to make textual adjustments and to adapt the article to the rules of publication.
Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg publish in institutional repository or as book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of the published work (See The Effect of Free Access) at http://opcit.eprints.org/oacitation-biblio.html
References
BERNER, T.; NAKAHARA, K.; KOBAYASHI. E.; TANAKA. A.; TANIGUCHI. Y.; IIZUKA. T.; SAWADA. K. Investigating the effect of antiseptic solution on the release of interleukin-6 and transforming growth factor beta 1 from human gingival fibroblasts using wound healing assays. Journal of oral science, v. 62, n. 3, p. 293-297, 2020.
CABRAL, C.T.; FERNANDES, M.H. In vitro comparison of chlorhexidine and povidone–iodine on the long-term proliferation and functional activity of human alveolar bone cells. Clinical Oral Investigations, v. 11, p. 155-164, 2007.
CHEN, Z.; ZHANG, Y.; WANG, D.; LI, L.; ZHOU, S.; HUANG, J. H.; CHEN, J.; HU, P.; HUANG, M. Photodynamic antimicrobial chemotherapy using zinc phthalocyanine derivatives in treatment of bacterial skin infection. Journal of biomedical optics, v. 21, n. 1, p. 018001-018001, 2016.
COELHO, A. S.; LARANJO, M.; GONÇALVES; A. C., PAULA, A.; PAULO, S.; ABRANTES, A. M.; CARAMELO, F.; FERREIRA, M. M.; SILVA, M. J.; CARRILHO, E.; BPTELHO, M. F. Cytotoxic effects of a chlorhexidine mouthwash and of an enzymatic mouthwash on human gingival fibroblasts. Odontology, v. 108, p. 260-270, 2020.
DOAN, L.; PISKOUN, B.; ROSENBERG, A. D.; BLANCK, T. J.; PHILLIPS, M. S.; XU, F. In vitro antiseptic effects on viability of neuronal and Schwann cells. Regional Anesthesia & Pain Medicine, v. 37, n. 2, p. 131-138, 2012.
DOGAN, S.; GÜNAY, H.; LEYHAUSEN, G.; GEURTSEN, W. Effects of low-concentrated chlorhexidine on growth of Streptococcus sobrinus and primary human gingival fibroblasts. Clinical Oral Investigations, v. 7, p. 212-216, 2003.
FLÖTRA, L.; GJERMO, P.; RÖLLA, G.; WAERHAUG, J. Side effects of chlorhexidine mouth washes. European Journal of Oral Sciences, v. 79, n. 2, p. 119-125, 1971.
GIANNELLI, M.; CHELLINI, F.; MARGHERI, M.; TONELLI, P.; TANI, A. Effect of chlorhexidine digluconate on different cell types: a molecular and ultrastructural investigation. Toxicology in vitro, v. 22, n. 2, p. 308-317, 2008.
HIDALGO, E.; DOMINGUEZ, C. Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicology in vitro, v. 15, n. 4-5, p. 271-276, 2001.
HORTENSE, S. R.; CARVALHO, É. DA S.; CARVALHO, F. S. DE; SILVA, R. P. R. DA; BASTOS, J. R. DE M.; BASTOS, R. DA S. Uso da clorexidina como agente preventivo e terapêutico na odontologia. Revista de Odontologia da Universidade Cidade de São Paulo, v. 22, n. 2, p. 178-184, 2010.
Liu, J. X.; Werner, J.; Kirsch, T.; Zuckerman, J. D.; Virk, M. S. Cytotoxicity evaluation of chlorhexidine gluconate on human fibroblasts, myoblasts, and osteoblasts. Journal of bone and joint infection, v. 3, n. 4, p. 165-172, 2018.
LÖE, H.; RINDOM, S.C. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. Journal of periodontal research, v. 5, n. 2, p. 79-83, 1970.
MADHUSUDANAN, S.; RENJITH, A. Comparative Evaluation of Cytotoxicity of 0.12% and 0.2% Chlorhexidine, 2% Povidone Iodine, 3% Hydrogen Peroxide and 0.9% Normal Saline Solutions on Fibroblasts-An Invitro Study. Journal of Clinical & Diagnostic Research, v. 14, n. 9, 2020.
MARIOTTI, A. J.; RUMPF, D. AH. Chlorhexidine‐induced changes to human gingival fibroblast collagen and non‐collagen protein production. Journal of periodontology, v. 70, n. 12, p. 1443-1448, 1999.
MÜLLER, G.; KRAMER, A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. Journal of Antimicrobial Chemotherapy, v. 61, n. 6, p. 1281-1287, 2008.
ORCINA, B.D.F; REIA, V.B; SANTOS, C.A; PERES, M.H; VILHENA, F.V; SANTOS, P.S.S. Antibacterial and antifungal activity of intraoral products containing phthalocyanine: In vitro study. 2021.
ORCINA, B. F.; PIETRO, E. C. I. N.; KURODA, J. P. G.; ALVES, L. M. C.; RAGGHIANTI, M. S.; OLIVEIRA, R. C.; SIMÃO, A. N. C.; VILHENA, F. V.; SANTOS, P.S.S. Oral Antiseptic Spray Containing Phthalocyanine Solution Reduced Saliva SARS-CoV-2 Viral Load: Case Series. International Archives of Otorhinolaryngology, v. 26, p. 293-295, 2022.
ORCINA, B. F.; SANTOS, P.S.S. Oral manifestation COVID-19 and the rapid resolution of symptoms post-phtalox treatment: a case series. Int. J. Odontostomat, v. 15, n. 1, p. 67-70, 2021.
PEGORARO, J.; SILVESTRI, L.; CARA, G.; STEFENON, L.; MOZZINI, C. B. Efeitos adversos do gluconato de clorexidina à 0, 12%. Journal of Oral Investigations, v. 3, n. 1, p. 33-37, 2015.
POLETI, M. L.; GREGÓRIO, D.; BISTAFFA, A. G. I.; VILHENA, F. V.; SIMÃO, A. N. C.; MORI, M. T. E.; STADTLOBER, N. P.; LOZOVOY, M. A. B.; SANTOS, P. S. S.; TATIBANA, B. T.; FERNANDES, T. M. F. Toothbrushing with a dentifrice containing antimicrobial phthalocyanine derivative for the intraoral reduction of viral load of SARS-CoV-2: a pilot study. 2021.
PUCHER, J. J.; DANIEL, C. The effects of chlorhexidine digluconate on human fibroblasts in vitro. Journal of periodontology, v. 63, n. 6, p. 526-532, 1992.
REDDING, W. R.; BOOTH, L. C. Effects of Chlorhexidine Gluconate and Chlorous Acid‐Chlorine Dioxide on Equine Fibroblasts and Staphylococcus aureus. Veterinary Surgery, v. 20, n. 5, p. 306-310, 1991.
RIBEIRO, A. P.; ANDRADE, M. C.; BAGNATO, V. S.; VERGANI, C. E.; PRIMO, F. L.; TEDESCO, A. C.; PAVARINA, A. C. Antimicrobial photodynamic therapy against pathogenic bacterial suspensions and biofilms using chloro-aluminum phthalocyanine encapsulated in nanoemulsions. Lasers in medical science, v. 30, p. 549-559, 2015.
RICHARDS, D. Chlorhexidine mouthwash plaque levels and gingival health. Evidence-based dentistry, v. 18, n. 2, p. 37-38, 2017.
SAWADA, K.; CABALLÉ-SERRANO, J.; BOSSHARDT, D. D.; SCHALLER, B.; MIRON, R. J.; BUSER, D.; GRUBER, R. Antiseptic solutions modulate the paracrine‐like activity of bone chips: differential impact of chlorhexidine and sodium hypochlorite. Journal of clinical periodontology, v. 42, n. 9, p. 883-891, 2015.
SANTOS, C.; TEODORO, G.; SIBELINO, S.; NOVAES, P.; FARIAS, M.; VILHENA, F. Antibiofilm action of PHTALOX®-containing oral care formulations. J Dent Res, v. 99, n. Spec Iss A, p. abstract number, 3326, 2020.
SANTOS, C; ORCINA, B.F; REIA, V. C.B; RIBEIRO, L. G.; GROTTO, R. M. T.; PRUDENCIATTI, A.; MORAES, L. N.; ZANGRANDO, M.R; VILHENA, F. V.; SANTOS, P. S.S. Virucidal activity of the antiseptic mouthwash and dental gel containing anionic phthalocyanine derivative: in vitro study. Clinical, Cosmetic and Investigational Dentistry, p. 269-274, 2021.
SANTOS, C.; RAGGHIANTI, M.; VILHENA, F. V. Adjuvant use of phthalocyanine derivative for calculus control. International Journal of Case Reports and Images, v. 12, p. 101220-101221, 2021.
SANTOS, P. S.S; ORCINA, B.F; MACHADO, R. R. G.; VILHENA, F. V.; ALVES, L. M.C; ZANGRANDO, M. S. R.; OLIVEIRA, R. C.; SOARES, M. Q. S.; SIMÃO, A. N. C.; PIETRO, E. C. I. N.; KURODA, J. P. G.; BENJAMIM, I. A.; ARAUJO, D. B.; TOMA, S. H.; FLOR, L.; ARAKI, K.; DURIGON, E. L. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial. Scientific reports, v. 11, n. 1, p. 19937, 2021.
SCHMIDT, J.; ZYBA, V.; JUNG, K.; RINKE, S.; HAAK, R.; MAUSBERG, R. F.; ZIEBOLZ, D. Cytotoxic effects of octenidine mouth rinse on human fibroblasts and epithelial cells–an in vitro study. Drug and Chemical Toxicology, v. 39, n. 3, p. 322-330, 2016.
SEN, C. K. Wound healing essentials: let there be oxygen. Wound repair and regeneration, v. 17, n. 1, p. 1-18, 2009.
SUKUMARAN, S. K.; VADAKKEKUTTICAL, R. J.; KANAKATH, H. Comparative evaluation of the effect of curcumin and chlorhexidine on human fibroblast viability and migration: An in vitro study. Journal of Indian Society of Periodontology, v. 24, n. 2, p. 109, 2020.
TEODORO, G.; SANTOS, C.; CAMPOS, M.A.; KOGA-ITO, C.; SIBELINO, S.; VILHENA, F. PHTALOX® antimicrobial action and cytotoxicity: in vitro study. J Dent Res, v. 99, n. SpecIss A, 2020.
THOMAS, G. W.; RAEL, L. T.; BAR-OR, R.; SHIMONKEVITZ, R.; MAINS, C. W.; SLONE, D. S.; CRAUN, M. L.; BAR-OR, D. Mechanisms of delayed wound healing by commonly used antiseptics. Journal of Trauma and Acute Care Surgery, v. 66, n. 1, p. 82-91, 2009.
TSOUROUNAKIS, I.; PALAIOLOGOU-GALLIS, A. A.; STOUTE, D.; MANEY, P.; LALLIER, T. E. Effect of essential oil and chlorhexidine mouthwashes on gingival fibroblast survival and migration. Journal of periodontology, v. 84, n. 8, p. 1211-1220, 2013.
VALLEJO, M. C. S.; MOURA, N. M. M.; GOMES, A. T. P. C.; JOAQUINITO, A. S. M.; FAUSTINO, M. A. F.; ALMEIDA, A.; GONÇALVES, I.; SERRA, V. V.; NEVES, M. G. P. M. S. The role of porphyrinoid photosensitizers for skin wound healing. International Journal of Molecular Sciences, v. 22, n. 8, p. 4121, 2021.
VILHENA, F. V.; ORCINA, B. D. F.; LEMOS, L.; LESS, J. C. F.; PINTO, I.; SANTOS, P. S. D. S. Elimination of SARS-CoV-2 in nasopharynx and oropharynx after use of an adjuvant gargling and rinsing protocol with an antiseptic mouthwash. Einstein (Sao Paulo), v. 19, 2022.
WESTFELT, E. Rationale of mechanical plaque control. Journal of clinical periodontology, v. 23, n. 3, p. 263-267, 1996.
WYGANOWSKA-SWIATKOWSKA, M.; KOTWICKA, M.; URBANIAK, P.; NOWAK, A.; SKRZYPCZAK-JANKUN, E.; JANKUN, J. Clinical implications of the growth-suppressive effects of chlorhexidine at low and high concentrations on human gingival fibroblasts and changes in morphology. International Journal of Molecular Medicine, v. 37, n. 6, p. 1594-1600, 2016.
YAYLI, N. A.; TUNC, S. K.; DEGIRMENCI, B. U.; DIKILITAS, A.; TASPINAR, M. Comparative evaluation of the cytotoxic effects of different oral antiseptics: A primary culture study. Nigerian Journal of Clinical Practice, v. 24, n. 3, p. 313-320, 2021.